IMMUCELL CORP /DE/ (ICCC) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2009: -$109.7K2010: -$808.6K2011: -$37.3K2012: $344.4K2013: $1.10M2014: $302.4K2015: $2.90M2016: -$222.3K2017: $1.18M2018: -$373.4K2019: $233.5K2020: $1.32M2021: $954.2K2022: -$1.54M2023: -$4.67M2024: $357.9K2025: $2.48M$2.48M
2009Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$2.48M+591.6%
2024$357.9K+107.7%
2023-$4.67M-202.8%
2022-$1.54M-261.8%
2021$954.2K-27.5%
2020$1.32M+463.4%
2019$233.5K+162.5%
2018-$373.4K-131.8%
2017$1.18M+628.9%
2016-$222.3K-107.7%
2015$2.90M+859.2%
2014$302.4K-72.5%
2013$1.10M+219.0%
2012$344.4K+1022.9%
2011-$37.3K+95.4%
2010-$808.6K-637.3%
2009-$109.7K